TotalMarketCap

Acurx Pharmaceuticals

ACXPNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$5.393 M

$0.97 -5.83%

Close of 6 Nov 2026

As of 6 Nov 2026, Acurx Pharmaceuticals (ACXP) has a market capitalization of $5.39M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$7.97M

Loss-making

Shares outstanding

5,269,921

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #444Bio Green Med SolutionBGMS$5.76M
  2. #445LongeveronLGVN$5.52M
  3. #446Acurx PharmaceuticalsACXP$5.39M
  4. #447Jaguar HealthJAGX$5.35M
  5. #448PulmatrixPULM$5.31M

What if Acurx Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$5,079,118

Per share 5,236,204× higher

Bitcoin $1.53T

$274,822.22

Per share 283,322× higher

Apple $5.02T

$902,215.70

Per share 930,119× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Acurx Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.